Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose GRC 6211 for pain after third molar extraction
2007-003976-20Phase 2Terminated
- Sponsor
- Glenmark Pharmaceuticals
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GRC6211 in postoperative pain (3 arms), sponsored by Glenmark Pharmaceuticals. Started Oct 2007; status: terminated.
02
Drugs
GRC6211
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2007-003976-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003976-20.